ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.96412
-0.05%
Brent Oil
83.945
0.38%
Bitcoin
59,406.69
0.48%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Allakos Inc (ALLK)

  7. Allakos Inc (ALLK) Noticias

ALLK Allakos Inc

1.10
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Allakos Inc ALLK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.10 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/3/202415:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
06/3/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:22EDGAR2Form 144 - Report of proposed sale of securities
04/3/202416:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202406:05EDGAR2Form 8-K - Current report
26/2/202406:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
21/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202406:07EDGAR2Form 8-K - Current report
12/2/202406:02GLOBEAllakos Announces Publication Highlighting AK006 Mast Cell..
02/2/202415:05EDGAR2Form 8-K - Current report
02/2/202411:31EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202416:00EDGAR2Form 8-K - Current report
16/1/202406:02GLOBEAllakos Announces a Restructuring to Focus on Development of..
16/1/202406:00GLOBEAllakos Announces Phase 2 Lirentelimab Trials in Atopic..
05/1/202415:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:49EDGAR2Form 144 - Report of proposed sale of securities
04/12/202314:31EDGAR2Form 144 - Report of proposed sale of securities
04/12/202314:21EDGAR2Form 144 - Report of proposed sale of securities
26/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202316:01EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202315:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:02GLOBEAllakos Provides Business Update and Reports Third Quarter..
07/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202315:06EDGAR2Form 144 - Report of proposed sale of securities
05/9/202314:57EDGAR2Form 144 - Report of proposed sale of securities
05/9/202314:52EDGAR2Form 144 - Report of proposed sale of securities
30/8/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:05EDGAR2Form 8-K - Current report
30/8/202315:05GLOBEAllakos Appoints Neil Graham to its Board of Directors
21/8/202315:02EDGAR2Form 8-K - Current report
09/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202315:08EDGAR2Form 8-K - Current report
09/8/202315:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
03/8/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202315:05GLOBEAllakos Appoints Rand Sutherland and Dolca Thomas to its..
02/8/202315:03EDGAR2Form 8-K - Current report
12/6/202306:02GLOBEAllakos Presents Preclinical Data at EAACI Hybrid Congress..

Su Consulta Reciente

NASDAQ
ALLK
Allakos
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados